Skip to main content

Rituxan Hycela Prices, Coupons, Copay Cards & Patient Assistance

Rituxan Hycela (hyaluronidase/rituximab) is a member of the CD20 monoclonal antibodies drug class and is commonly used for Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma.

The cost for Rituxan Hycela (23,400 units-1400 mg/11.7 mL) subcutaneous solution is around $6,935 for a supply of 11.7 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Rituxan Hycela prices

Subcutaneous Solution

23,400 units-1400 mg/11.7 mL

Rituxan Hycela subcutaneous solution

 from $6,934.64

for 11.7 milliliters
Quantity Per unit Price
11.7 milliliters $592.70 $6,934.64

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

26,800 units-1600 mg/13.4 mL

Rituxan Hycela subcutaneous solution

 from $7,923.94

for 13.4 milliliters
Quantity Per unit Price
13.4 milliliters $591.34 $7,923.94

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Rituxan Hycela Coupons, Copay Cards and Rebates

Rituxan Hycela offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Rituxan Hycela Genentech Oncology Co-pay Assistance Program

Eligible commercially insured patients may pay $0 in out-of-pocket costs for the prescribed product; savings of up to $25,000 per product per calendar year; for additional information contact the program at 855-692-6729.

Applies to:
Rituxan Hycela
Number of uses:
Per prescription per calendar year

Form more information phone: 855-692-6729 or Visit website

Rituxan Hycela Genentech Oncology Co-pay Assistance Program Rebate

Eligible commercially insured patients enrolled in the program may be entitled to a rebate for their out-of-pocket cost if they paid the provider directly for treatment; for additional information contact the program at 855-692-6729.

Applies to:
Rituxan Hycela
Number of uses:
One rebate per purchase

Form more information phone: 855-692-6729 or Visit website

Patient Assistance & Copay Programs for Rituxan Hycela

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: HealthWell Foundation Copay Program

Eligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Rituxan Hycela (rituximab-hyaluronidase human ) Injection; Subcutaneous

More information please phone: 800-675-8416 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Rituxan Hycela (rituximab-hyaluronidase human) Injection; Subcutaneous

More information please phone: 866-316-7263 Visit Website

Provider: Genentech Oncology Access Solutions

Eligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Varies
  4. Must be treated by US licensed healthcare provider
  5. Call for most recent medications as the list is subject to change. Eligibility determined on a case-by-case basis. Contact program for details.
Applicable drugs:
  • Rituxan Hycela (rituximab-hyaluronidase human) Injection; Subcutaneous

More information please phone: 888-249-4918   or 866-422-2377   Visit Website

Provider: Genentech Patient Foundation

Eligibility requirements:
  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Based on FPL
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Rituxan Hycela (rituximab-hyaluronidase human) Injection; Subcutaneous

More information please phone: 888-941-3331   or 866-422-2377   Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.